Genic (Korea) Market Value
123330 Stock | KRW 22,250 2,390 12.03% |
Symbol | Genic |
Genic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genic.
11/20/2024 |
| 12/20/2024 |
If you would invest 0.00 in Genic on November 20, 2024 and sell it all today you would earn a total of 0.00 from holding Genic Co or generate 0.0% return on investment in Genic over 30 days. Genic is related to or competes with Digital Power, Iljin Display, Inzi Display, Display Tech, Ssangyong Information, Hankook Furniture, and Innowireless. Genic Co., Ltd. researches, develops, manufactures, and sells hydrogel mask packs in South Korea and internationally More
Genic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genic Co upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 4.28 | |||
Information Ratio | 0.1109 | |||
Maximum Drawdown | 31.77 | |||
Value At Risk | (7.11) | |||
Potential Upside | 13.03 |
Genic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genic's standard deviation. In reality, there are many statistical measures that can use Genic historical prices to predict the future Genic's volatility.Risk Adjusted Performance | 0.1011 | |||
Jensen Alpha | 0.6923 | |||
Total Risk Alpha | 0.5249 | |||
Sortino Ratio | 0.1597 | |||
Treynor Ratio | 1.16 |
Genic Backtested Returns
Genic appears to be very steady, given 3 months investment horizon. Genic holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. By evaluating Genic's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please utilize Genic's Market Risk Adjusted Performance of 1.17, risk adjusted performance of 0.1011, and Downside Deviation of 4.28 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Genic holds a performance score of 10. The company retains a Market Volatility (i.e., Beta) of 0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genic is expected to be smaller as well. Please check Genic's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Genic's current trending patterns will revert.
Auto-correlation | -0.26 |
Weak reverse predictability
Genic Co has weak reverse predictability. Overlapping area represents the amount of predictability between Genic time series from 20th of November 2024 to 5th of December 2024 and 5th of December 2024 to 20th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genic price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Genic price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.26 | |
Spearman Rank Test | -0.66 | |
Residual Average | 0.0 | |
Price Variance | 2.1 M |
Genic lagged returns against current returns
Autocorrelation, which is Genic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genic's stock expected returns. We can calculate the autocorrelation of Genic returns to help us make a trade decision. For example, suppose you find that Genic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Genic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genic stock over time.
Current vs Lagged Prices |
Timeline |
Genic Lagged Returns
When evaluating Genic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genic stock have on its future price. Genic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genic autocorrelation shows the relationship between Genic stock current value and its past values and can show if there is a momentum factor associated with investing in Genic Co.
Regressed Prices |
Timeline |
Pair Trading with Genic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genic will appreciate offsetting losses from the drop in the long position's value.Moving against Genic Stock
The ability to find closely correlated positions to Genic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genic Co to buy it.
The correlation of Genic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genic Stock
Genic financial ratios help investors to determine whether Genic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genic with respect to the benefits of owning Genic security.